Venanprubart (LY-3361237) is a humanized monoclonal antibody designed as a BTLA/CD272 agonist for research use. It is applied in preclinical studies of autoimmune diseases like psoriasis, facilitating both in vitro mechanistic studies and in vivo model validation.
Concentration:
5 mg/mL
Molecular Weight:
145.15 kDa
Purity:
99.80% (May vary between batches)
CAS Number:
[2635407-50-8]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted